Search results
Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With...
Benzinga· 5 days agoData show favorable safety and feasibility in 68 heavily pre-treated patients with R/M-HNSCC (Intention-to-Treat population; "ITT") who received RT-activated NBTXR3 followed by anti-PD-1 as a second-or-later line
Fresno High School student overcomes roadblocks, graduates early
KSEE articles via Yahoo News· 3 days agoFRESNO, Calif. (KSEE/KGPE) – It was a proud moment for many graduates Monday at the Save Mart Center...
Attleboro mom gifts dogs to sick children in memory of daughter
NBC 10 Providence· 7 days agoAn Attleboro mom who lost her teenage daughter to cancer is doing all she can to keep her legacy...
Psirenity Health Adds Key Executive to its Experienced and Innovative Leadership Team
Digital Journal· 3 days ago... from Planned Interim Analysis of Pivotal IGNYTE-ESO Trial with Lete-cel at ASCO; Data Continue to Support further Development of Sarcoma Franchise Colibri Lists Common Shares on Frankfurt Stock Exchange Katipult Wins 2024 Tech of the Future Banking USA Award...
Evaluating Tumor Heterogeneity with a High Throughput Pipeline
The Scientist· 4 days agoThe success of nonclinical drug testing relies heavily on using models that accurately recapitulate complex biological processes. With the passing of the Food and Drug Administration (FDA) Modernization ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 2 days agoLive from ASCO 2024 | Oral Report Released Latest Data of Olverembatinib in SDH-Deficient GIST, Including a CBR of 92.3% PR Newswire SUZHOU, China and ROCKVILLE, Md., June 4, 2024 SUZHOU, China ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 5 days agoData show favorable safety and feasibility in 68 heavily pre-treated patients with R/M-HNSCC (Intention-to-Treat population; “ITT”) who received RT-activated NBTXR3 followed by anti-PD-1 as a second-or-later line treatment48% ORR in evaluable
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 6 days agoIn honor of National Cancer Survivor Month this June, the St. Baldrick's Foundation, the largest charity funder of childhood cancer research grants, is launching its "Cancer-Free Isn't Free" ...